XML 44 R32.htm IDEA: XBRL DOCUMENT v3.25.1
REVENUE - Summary of Analysis of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Disclosure of disaggregation of revenue from contracts with customers [line items]    
License revenue $ 9,348 $ 12,181
Collaboration revenue 185,615 78,481
Other revenue 90 3,329
Total revenue 195,053 93,991
Novartis    
Disclosure of disaggregation of revenue from contracts with customers [line items]    
License revenue $ 9,348 $ 12,181